TY - STD TI - American Cancer Society, 2013. Cancer Facts & Figures. ACS website: ., [http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013] UR - http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013 ID - ref1 ER - TY - JOUR AU - Gogas, H. AU - Polyzos, A. AU - Kirkwood, J. PY - 2013 DA - 2013// TI - Immunotherapy for advanced melanoma: fulfilling the promise JO - Cancer Treat Rev VL - 39 UR - https://doi.org/10.1016/j.ctrv.2013.04.006 DO - 10.1016/j.ctrv.2013.04.006 ID - Gogas2013 ER - TY - JOUR AU - Mellman, I. AU - Coukos, G. AU - Dranoff, G. PY - 2011 DA - 2011// TI - Cancer immunotherapy comes of age JO - Nature VL - 480 UR - https://doi.org/10.1038/nature10673 DO - 10.1038/nature10673 ID - Mellman2011 ER - TY - JOUR AU - Ascierto, P. A. AU - Simeone, E. AU - Sznol, M. AU - Fu, Y. X. AU - Melero, I. PY - 2010 DA - 2010// TI - Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies JO - Semin Oncol VL - 37 UR - https://doi.org/10.1053/j.seminoncol.2010.09.008 DO - 10.1053/j.seminoncol.2010.09.008 ID - Ascierto2010 ER - TY - JOUR AU - Mittendorf, E. A. AU - Clifton, G. T. AU - Holmes, J. P. AU - Clive, K. S. AU - Patil, R. AU - Benavides, L. C. AU - Gates, J. D. AU - Sears, A. K. AU - Stojadinovic, A. AU - Ponniah, S. AU - Peoples, G. E. PY - 2012 DA - 2012// TI - Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02 JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.26574 DO - 10.1002/cncr.26574 ID - Mittendorf2012 ER - TY - JOUR AU - Baselga, J. AU - Cortes, J. AU - Kim, S. B. AU - Im, S. A. AU - Hegg, R. AU - Im, Y. H. AU - Roman, L. AU - Pedrini, J. L. AU - Pienkowski, T. AU - Knott, A. AU - Clark, E. AU - Benyunes, M. C. AU - Ross, G. AU - Swain, S. M. PY - 2012 DA - 2012// TI - Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1113216 DO - 10.1056/NEJMoa1113216 ID - Baselga2012 ER - TY - JOUR AU - Khasraw, M. AU - Bell, R. PY - 2012 DA - 2012// TI - Primary systemic therapy in HER2-amplified breast cancer: a clinical review JO - Expert Rev Anticancer Ther VL - 12 UR - https://doi.org/10.1586/era.12.62 DO - 10.1586/era.12.62 ID - Khasraw2012 ER - TY - STD TI - Ataullakhonov RI, Melnikova TM, Khaitov RM, Pichugin AV: Plant extract active as an immunostimulating agent. United States Patent Application Publication. Pub. No.: US 2005/0042236 A1. Pub. Date: Feb. 24, 2005. ID - ref8 ER - TY - JOUR AU - Ghochikyan, A. AU - Davtyan, A. AU - Hovakimyan, A. AU - Davtyan, H. AU - Poghosyan, A. AU - Bagaev, A. AU - Ataullakhanov, R. I. AU - Nelson, E. L. AU - Agadjanyan, M. G. PY - 2014 DA - 2014// TI - Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy JO - Clin Exp Metastasis VL - 31 UR - https://doi.org/10.1007/s10585-013-9619-0 DO - 10.1007/s10585-013-9619-0 ID - Ghochikyan2014 ER - TY - JOUR AU - Vasilevko, V. AU - Ghochikyan, A. AU - Sadzikava, N. AU - Petrushina, I. AU - Tran, M. AU - Cohen, E. P. AU - Kesslak, P. J. AU - Cribbs, D. H. AU - Nicolson, G. L. AU - Agadjanyan, M. G. PY - 2003 DA - 2003// TI - Immunization with a vaccine that combines the expression of MUC1 and B7 co-stimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumors JO - Clin Exp Metastasis VL - 20 UR - https://doi.org/10.1023/A:1025802610724 DO - 10.1023/A:1025802610724 ID - Vasilevko2003 ER - TY - JOUR AU - Loukinov, D. AU - Ghochikyan, A. AU - Mkrtichyan, M. AU - Ichim, T. E. AU - Lobanenkov, V. V. AU - Cribbs, D. H. AU - Agadjanyan, M. G. PY - 2006 DA - 2006// TI - Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant JO - J Cell Biochem VL - 98 UR - https://doi.org/10.1002/jcb.20953 DO - 10.1002/jcb.20953 ID - Loukinov2006 ER - TY - JOUR AU - Mkrtichyan, M. AU - Ghochikyan, A. AU - Loukinov, D. AU - Davtyan, H. AU - Ichim, T. E. AU - Cribbs, D. H. AU - Lobanenkov, V. V. AU - Agadjanyan, M. G. PY - 2008 DA - 2008// TI - DNA, but not protein vaccine based on mutated BORIS antigen significantly inhibits tumor growth and prolongs the survival of mice JO - Gene Ther VL - 15 UR - https://doi.org/10.1038/sj.gt.3303044 DO - 10.1038/sj.gt.3303044 ID - Mkrtichyan2008 ER - TY - CHAP AU - Pulaski, B. A. AU - Ostrand-Rosenberg, S. ED - Coligan, J. E. ED - Kruisbeek, A. M. ED - Margulies, D. H. ED - Shevach, E. M. ED - Strober, W. PY - 2001 DA - 2001// TI - Mouse 4T1 Breast Tumor Model BT - Current Protocols in Immunology PB - John Wiley CY - New York ID - Pulaski2001 ER - TY - JOUR AU - Monzavi-Karbassi, B. AU - Whitehead, T. L. AU - Jousheghany, F. AU - Artaud, C. AU - Hennings, L. AU - Shaaf, S. AU - Slaughter, A. AU - Korourian, S. AU - Kelly, T. AU - Blaszczyk-Thurin, M. AU - Kieber-Emmons, T. PY - 2005 DA - 2005// TI - Deficiency in surface expression of E-selectin ligand promotes lung colonization in a mouse model of breast cancer JO - Int J Cancer VL - 117 UR - https://doi.org/10.1002/ijc.21192 DO - 10.1002/ijc.21192 ID - Monzavi-Karbassi2005 ER - TY - JOUR AU - Mkrtichyan, M. AU - Ghochikyan, A. AU - Davtyan, H. AU - Movsesyan, N. AU - Loukinov, D. AU - Lobanenkov, V. AU - Cribbs, D. H. AU - Laust, A. K. AU - Nelson, E. L. AU - Agadjanyan, M. G. PY - 2011 DA - 2011// TI - Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma JO - Cell Immunol VL - 270 UR - https://doi.org/10.1016/j.cellimm.2011.05.007 DO - 10.1016/j.cellimm.2011.05.007 ID - Mkrtichyan2011 ER - TY - JOUR AU - Tukhvatulin, A. I. AU - Gitlin, I. I. AU - Shcheblyakov, D. V. AU - Artemicheva, N. M. AU - Burdelya, L. G. AU - Shmarov, M. M. AU - Naroditsky, B. S. AU - Gudkov, A. V. AU - Gintsburg, A. L. AU - Logunov, D. Y. PY - 2013 DA - 2013// TI - Combined stimulation of Toll-like receptor 5 and NOD1 strongly potentiates activity of NF-kappaB, resulting in enhanced innate immune reactions and resistance to Salmonella enterica serovar Typhimurium infection JO - Infect Immun VL - 81 UR - https://doi.org/10.1128/IAI.00525-13 DO - 10.1128/IAI.00525-13 ID - Tukhvatulin2013 ER - TY - JOUR AU - Pulaski, B. A. AU - Terman, D. S. AU - Khan, S. AU - Muller, E. AU - Ostrand-Rosenberg, S. PY - 2000 DA - 2000// TI - Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model JO - Cancer Res VL - 60 ID - Pulaski2000 ER - TY - JOUR AU - Bunt, S. K. AU - Yang, L. AU - Sinha, P. AU - Clements, V. K. AU - Leips, J. AU - Ostrand-Rosenberg, S. PY - 2007 DA - 2007// TI - Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-2354 DO - 10.1158/0008-5472.CAN-07-2354 ID - Bunt2007 ER - TY - JOUR AU - Younos, I. AU - Donkor, M. AU - Hoke, T. AU - Dafferner, A. AU - Samson, H. AU - Westphal, S. AU - Talmadge, J. PY - 2011 DA - 2011// TI - Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells JO - Int Immunopharmacol VL - 11 UR - https://doi.org/10.1016/j.intimp.2011.02.021 DO - 10.1016/j.intimp.2011.02.021 ID - Younos2011 ER - TY - JOUR AU - Ataullakhanov, R. I. AU - Pichugin, A. V. AU - Shishkova, N. M. AU - Masternak, T. B. AU - Malkina, E. Y. AU - Ulyanova, L. I. PY - 2005 DA - 2005// TI - Cellular mechanisms of immunomodulating action of the drug “Immunomax” JO - Immunologia VL - 2 ID - Ataullakhanov2005 ER - TY - JOUR AU - Ataullakhanov, R. AU - Tishchenko, A. L. AU - Bauer, H. W. AU - Grigoryan, V. AU - Shpot, E. AU - vor dem Esche, U. AU - Zgaga-Griesz, A. AU - Bessler, W. G. PY - 2010 DA - 2010// TI - ImmunomaxR therapy to obtain relief in papilloma virus infections, prostatitis, and prostate carcinoma JO - J Mens Health VL - 7 UR - https://doi.org/10.1016/j.jomh.2010.10.005 DO - 10.1016/j.jomh.2010.10.005 ID - Ataullakhanov2010 ER - TY - JOUR AU - Lauzon, N. M. AU - Mian, F. AU - Ashkar, A. A. PY - 2007 DA - 2007// TI - Toll-like receptors, natural killer cells and innate immunity JO - Adv Exp Med Biol VL - 598 UR - https://doi.org/10.1007/978-0-387-71767-8_1 DO - 10.1007/978-0-387-71767-8_1 ID - Lauzon2007 ER - TY - JOUR AU - Moretta, A. PY - 2002 DA - 2002// TI - Natural killer cells and dendritic cells: rendezvous in abused tissues JO - Nat Rev Immunol VL - 2 UR - https://doi.org/10.1038/nri956 DO - 10.1038/nri956 ID - Moretta2002 ER - TY - JOUR AU - Ferlazzo, G. AU - Tsang, M. L. AU - Moretta, L. AU - Melioli, G. AU - Steinman, R. M. AU - Munz, C. PY - 2002 DA - 2002// TI - Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells JO - J Exp Med VL - 195 UR - https://doi.org/10.1084/jem.20011149 DO - 10.1084/jem.20011149 ID - Ferlazzo2002 ER - TY - JOUR AU - Gerosa, F. AU - Baldani-Guerra, B. AU - Nisii, C. AU - Marchesini, V. AU - Carra, G. AU - Trinchieri, G. PY - 2002 DA - 2002// TI - Reciprocal activating interaction between natural killer cells and dendritic cells JO - J Exp Med VL - 195 UR - https://doi.org/10.1084/jem.20010938 DO - 10.1084/jem.20010938 ID - Gerosa2002 ER - TY - JOUR AU - Schreibelt, G. AU - Tel, J. AU - Sliepen, K. H. AU - Benitez-Ribas, D. AU - Figdor, C. G. AU - Adema, G. J. AU - de Vries, I. J. PY - 2010 DA - 2010// TI - Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy JO - Cancer Immunol Immunother VL - 59 UR - https://doi.org/10.1007/s00262-010-0833-1 DO - 10.1007/s00262-010-0833-1 ID - Schreibelt2010 ER - TY - JOUR AU - Kawamoto, T. AU - Ii, M. AU - Kitazaki, T. AU - Iizawa, Y. AU - Kimura, H. PY - 2008 DA - 2008// TI - TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain JO - Eur J Pharmacol VL - 584 UR - https://doi.org/10.1016/j.ejphar.2008.01.026 DO - 10.1016/j.ejphar.2008.01.026 ID - Kawamoto2008 ER - TY - JOUR AU - Matsunaga, N. AU - Tsuchimori, N. AU - Matsumoto, T. AU - Ii, M. PY - 2011 DA - 2011// TI - TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules JO - Mol Pharmacol VL - 79 UR - https://doi.org/10.1124/mol.110.068064 DO - 10.1124/mol.110.068064 ID - Matsunaga2011 ER - TY - JOUR AU - Mai, C. W. AU - Kang, Y. B. AU - Pichika, M. R. PY - 2013 DA - 2013// TI - Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers JO - Onco Targets Ther VL - 6 ID - Mai2013 ER - TY - JOUR AU - Ahmed, A. AU - Redmond, H. P. AU - Wang, J. H. PY - 2013 DA - 2013// TI - Links between Toll-like receptor 4 and breast cancer JO - Oncoimmunology VL - 2 UR - https://doi.org/10.4161/onci.22945 DO - 10.4161/onci.22945 ID - Ahmed2013 ER - TY - JOUR AU - Ahmed, A. AU - Wang, J. H. AU - Redmond, H. P. PY - 2013 DA - 2013// TI - Silencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancer JO - Ann Surg Oncol VL - 20 UR - https://doi.org/10.1245/s10434-012-2595-9 DO - 10.1245/s10434-012-2595-9 ID - Ahmed2013 ER - TY - JOUR AU - Engelhardt, R. AU - Mackensen, A. AU - Galanos, C. PY - 1991 DA - 1991// TI - Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients JO - Cancer Res VL - 51 ID - Engelhardt1991 ER - TY - JOUR AU - Mackensen, A. AU - Galanos, C. AU - Engelhardt, R. PY - 1991 DA - 1991// TI - Treatment of cancer patients with endotoxin induces release of endogenous cytokines JO - Pathobiology VL - 59 UR - https://doi.org/10.1159/000163659 DO - 10.1159/000163659 ID - Mackensen1991 ER - TY - STD TI - A service of the U.S. National Institutes of Health, website: Clinicaltrials.gov Identifier: NCT01585350, NCT01699347, NCT00010452, NCT00795977, NCT00291473, NCT01149902., ID - ref34 ER - TY - JOUR AU - Cheever, M. A. PY - 2008 DA - 2008// TI - Twelve immunotherapy drugs that could cure cancers JO - Immunol Rev VL - 222 UR - https://doi.org/10.1111/j.1600-065X.2008.00604.x DO - 10.1111/j.1600-065X.2008.00604.x ID - Cheever2008 ER - TY - JOUR AU - Hurwitz, A. A. AU - Yu, T. F. AU - Leach, D. R. AU - Allison, J. P. PY - 1998 DA - 1998// TI - CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.17.10067 DO - 10.1073/pnas.95.17.10067 ID - Hurwitz1998 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. AU - Powderly, J. D. AU - Carvajal, R. D. AU - Sosman, J. A. AU - Atkins, M. B. AU - Leming, P. D. AU - Spigel, D. R. AU - Antonia, S. J. AU - Horn, L. AU - Drake, C. G. AU - Pardoll, D. M. AU - Chen, L. AU - Sharfman, W. H. AU - Anders, R. A. AU - Taube, J. M. AU - McMiller, T. L. AU - Xu, H. AU - Korman, A. J. AU - Jure-Kunkel, M. AU - Agrawal, S. AU - McDonald, D. AU - Kollia, G. D. AU - Gupta, A. AU - Wigginton, J. M. AU - Sznol, M. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Phan, G. Q. AU - Yang, J. C. AU - Sherry, R. M. AU - Hwu, P. AU - Topalian, S. L. AU - Schwartzentruber, D. J. AU - Restifo, N. P. AU - Haworth, L. R. AU - Seipp, C. A. AU - Freezer, L. J. AU - Morton, K. E. AU - Mavroukakis, S. A. AU - Duray, P. H. AU - Steinberg, S. M. AU - Allison, J. P. AU - Davis, T. A. AU - Rosenberg, S. A. PY - 2003 DA - 2003// TI - Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1533209100 DO - 10.1073/pnas.1533209100 ID - Phan2003 ER -